Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Interaction of Plasmacytoid Dendritic Cells and Myeloma Cells Trigger Tumor Promoting Transcriptional Changes in Multiple Myeloma Cells

Arghya Ray, PhD, Leutz Buon, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2019) 134 (Supplement_1): 510.

https://doi.org/10.1182/blood-2019-123333

Published: 2019

Journal Articles

Plasmacytoid Dendritic Cells Trigger Contact-Dependent Tumor Promoting Genetic Alterations in Multiple Myeloma Cells

Arghya Ray, PhD, Leutz Buon, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2018) 132 (Supplement 1): 244.

https://doi.org/10.1182/blood-2018-99-117887

Published: 2018

Journal Articles

Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Adoptive Cell Therapy in Acute Myeloid Leukemia

Michael Boyiadzis, MD MHSc, Chang Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2016) 128 (22): 1609.

https://doi.org/10.1182/blood.V128.22.1609.1609

Published: 2016

Journal Articles

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Marion Eveillard, PharmD, PhD, Victor Floc'h, Nelly Robillard, PhD, Camille Debord, Soraya Wuilleme, PharmD, PhD, Richard Garand, Fanny Rialland, MD, Caroline Thomas, Pierre Peterlin, MD, Thierry Guillaume, MD PhD, Philippe Moreau, Patrice Chevallier, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2016) 128 (22): 5268.

https://doi.org/10.1182/blood.V128.22.5268.5268

Published: 2016

Journal Articles

CD38 and Antibody Therapy: What Can Basic Science Add?

Fabio Malavasi, MD, Antonella Chillemi, PhD, Barbara Castella, PhD, Ilaria Schiavoni, PhD, Danny Incarnato, PhD, Stefania Oliva, MD, Alberto L Horenstein, PhD

Blood (2016) 128 (22): SCI-36.

https://doi.org/10.1182/blood.V128.22.SCI-36.SCI-36

Published: 2016

Journal Articles

Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity

Denise Toscani, PhD, Marina Bolzoni, PhD, Federica Costa, Valeria Quarona, Valentina Marchica, Cristina Mancini, MD, Eugenia Martella, MD, Sabrina Bonomini, Paola Storti, PhD, Antonella Chillemi, PhD, Fabrizio Accardi, MD, Benedetta Dalla Palma, MD, Luisa Craviotto, MD, Fabio Malavasi, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2015) 126 (23): 2959.

https://doi.org/10.1182/blood.V126.23.2959.2959

Published: 2015

Journal Articles

Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment

Sara Serra, PhD, Davide Brusa, PhD, Tiziana Vaisitti, PhD, Roberta Buonincontri, PhD, Valentina Audrito, PhD, Marta Coscia, MD PhD, Davide Rossi, MD PhD, Erica B. Bhavsar, Richard R. Furman, MD, Gianluca Gaidano, MD PhD, Silvia Deaglio, MD PhD

Blood (2015) 126 (23): 4145.

https://doi.org/10.1182/blood.V126.23.4145.4145

Published: 2015

Journal Articles

Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells

Antonella Chillemi, PhD, Valeria Quarona, Andrea Zito, Fabio Morandi, PhD, Danilo Marimpietri, Massimiliano Cuccioloni, PhD, Oldham J Robert, Cragg S Mark, PhD, Marina Bolzoni, PhD, Denise Toscani, PhD, Vito Pistoia, MD, Nicola Giuliani, MD PhD, Alberto L Horenstein, PhD, Kate Sasser, PhD, Fabio Malavasi, MD

Blood (2015) 126 (23): 1849.

https://doi.org/10.1182/blood.V126.23.1849.1849

Published: 2015

Journal Articles

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Seiko Ishida, MD PhD, Yoshifumi Takei, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD, Kazuhiro Morishita, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD

Blood (2015) 126 (23): 591.

https://doi.org/10.1182/blood.V126.23.591.591

Published: 2015

Journal Articles

The Retinoid Derivative Drug, Acitretin, Modulates CD38 Expression on MEC-1 Cells and Primary Chronic Lymphocytic Leukemia (CLL) Cells and Reduces Migration in Response to the Chemokine CXCL12

Sally Elsir Mohammed, MBBS, MRCP(UK), Philip Murphy, MD, John Quinn, Patrick Thornton, FRCPath, Stephen Bergin, Bryan Hennessy

Blood (2015) 126 (23): 5271.

https://doi.org/10.1182/blood.V126.23.5271.5271

Published: 2015

Journal Articles

Ectoenzymes and Their Products As Communicators in the Human Myeloma Niche

Alberto L. Horenstein, PhD, Valentina Ferri, Marina Bolzoni, Valeria Quarona, Antonella Chillemi, Gianluca Zaccarello, Nicola Giuliani, MD PhD, Fabio Malavasi, MD PhD

Blood (2014) 124 (21): 2064.

https://doi.org/10.1182/blood.V124.21.2064.2064

Published: 2014

Journal Articles

Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79

Jeroen Lammerts van Bueren, PhD, Danielle Jakobs, Niels Kaldenhoven, Marcel Roza, Sanne Hiddingh, Joyce Meesters, Marleen Voorhorst, Elke Gresnigt, Luus Wiegman, Antonio Ortiz Buijsse, Grietje Andringa, Marije B. Overdijk, PhD, Parul Doshi, PhD, Kate Sasser, Michel de Weers, PhD, Paul W.H.I. Parren, PhD

Blood (2014) 124 (21): 3474.

https://doi.org/10.1182/blood.V124.21.3474.3474

Published: 2014

Journal Articles

Bone Marrow Cell Based Enzyme Replacement Prolongs Survival and Improves Disease Phenotypes In a Mouse Model Of Lethal Hypophosphatasia

Osamu Iijima, PhD, Koichi Miyake, MD, PhD, Aki Nakamura, DDS, Tsutomu Igarashi, MD, PhD, Chizu Kanokoda, Atsushi Watanabe, MD, PhD, Takashi Shimada, MD, PhD

Blood (2013) 122 (21): 2897.

https://doi.org/10.1182/blood.V122.21.2897.2897

Published: 2013

Journal Articles

Rescue of Lethal Hypophosphatasia Mice by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells.

Osamu Iijima, PhD, Koichi Miyake, MD, PhD, Hanako Sugano-Tajima, MD, PhD, Tsutomu Igarashi, MD, PhD, Chizu Kanokoda, Atsushi Watanabe, MD, PhD, Takashi Shimada, MD, PhD

Blood (2012) 120 (21): 3154.

https://doi.org/10.1182/blood.V120.21.3154.3154

Published: 2012

Journal Articles

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Damian J. Green, MD, Nural N. Orgun, Mark D. Hylarides, PhD, John M. Pagel, MD, PhD, Donald K. Hamlin, D. Scott Wilbur, PhD, Yukang Lin, PhD, Amiee L. Kenoyer, Shani L. Frayo, BS, William I. Bensinger, MD, Ajay K. Gopal, MD, Johnnie J. Orozco, MD, PhD, Theodore A. Gooley, PhD, Brent L. Wood, MD, PhD, Oliver W. Press, MD, PhD

Blood (2011) 118 (21): 1842.

https://doi.org/10.1182/blood.V118.21.1842.1842

Published: 2011

Journal Articles

Phospholipase D1 Is Required for Regulated Secretion of VWF Induced by the B-Subunits of Shiga-Like Toxins 1 and 2

Jing Huang, PhD, MD, Fang Liu, J. Evan Sadler, MD, PhD

Blood (2010) 116 (21): 2113.

https://doi.org/10.1182/blood.V116.21.2113.2113

Published: 2010

Journal Articles

CD38 Gene Polymorphisms Contribute to Genetic Predisposition to B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Jamroziak, MD, PhD, Zofia Szemraj, Olga Grzybowska-Izydorczyk, MD, Janusz Szemraj, PhD, Barbara Cebula, PhD, Ewa Balcerczak, PhD, Ewa Wawrzyniak, PhD, Marek Mirowski, PhD, Tadeusz Robak, MD, PhD

Blood (2007) 110 (11): 491.

https://doi.org/10.1182/blood.V110.11.491.491

Published: 2007

Journal Articles

Connexin-43 Mediates Fcγ Receptor-Induced Calcium Signaling by Acting as an NAD/Cyclic ADP-Ribose Transporter.

Eun-Kyung Song, PhD, Young-Rae Lee, Ph.D, Hong-Nu Yu, Ph.D, So-Young Rah, Ph.D., Uh-Hyun Kim, Ph.D., Seun-Jin Lee, Ph.D, Jong-Suk Kim, Ph.D, Myung-Kwan Han, Ph.D

Blood (2007) 110 (11): 3853.

https://doi.org/10.1182/blood.V110.11.3853.3853

Published: 2007

Journal Articles

Expression of ectonucleotidase CD39 by Foxp3 + Treg cells: hydrolysis of extracellular ATP and immune suppression

Giovanna Borsellino, Markus Kleinewietfeld, Diletta Di Mitri, Alexander Sternjak, Adamo Diamantini, Raffaella Giometto, Sabine Höpner, Diego Centonze, Giorgio Bernardi, Maria Luisa Dell'Acqua, Paolo Maria Rossini, Luca Battistini, Olaf Rötzschke, Kirsten Falk

Blood (2007) 110 (4): 1225–1232.

https://doi.org/10.1182/blood-2006-12-064527

Published: 2007

Includes: Supplemental data

Journal Articles

Dasatinib (BMS354825) Inhibits IgE-Dependent Activation and Histamine Release in Human Blood Basophils.

Michael Kneidinger, MD, Peter Valent, MD, Karoline V. Gleixner, MD, Stefan Florian, MD, Alexandra Boehm, MD, Karoline Sonneck, MD, Margit Weghofer, Christian Lupinek, Susanne Vrtala, MD, Anja Vales, MD, Rudolf Valenta, MD, Giulio Superti-Furga, PhD, Francis Y. Lee, PhD

Blood (2006) 108 (11): 1365.

https://doi.org/10.1182/blood.V108.11.1365.1365

Published: 2006

NARROW

Interaction of Plasmacytoid Dendritic Cells and Myeloma Cells Trigger Tumor Promoting Transcriptional Changes in Multiple Myeloma Cells

Plasmacytoid Dendritic Cells Trigger Contact-Dependent Tumor Promoting Genetic Alterations in Multiple Myeloma Cells

Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Adoptive Cell Therapy in Acute Myeloid Leukemia

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

CD38 and Antibody Therapy: What Can Basic Science Add?

Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity

Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment

Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

The Retinoid Derivative Drug, Acitretin, Modulates CD38 Expression on MEC-1 Cells and Primary Chronic Lymphocytic Leukemia (CLL) Cells and Reduces Migration in Response to the Chemokine CXCL12

Ectoenzymes and Their Products As Communicators in the Human Myeloma Niche

Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79

Bone Marrow Cell Based Enzyme Replacement Prolongs Survival and Improves Disease Phenotypes In a Mouse Model Of Lethal Hypophosphatasia

Rescue of Lethal Hypophosphatasia Mice by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells.

Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

Phospholipase D1 Is Required for Regulated Secretion of VWF Induced by the B-Subunits of Shiga-Like Toxins 1 and 2

CD38 Gene Polymorphisms Contribute to Genetic Predisposition to B-Cell Chronic Lymphocytic Leukemia.

Connexin-43 Mediates Fcγ Receptor-Induced Calcium Signaling by Acting as an NAD/Cyclic ADP-Ribose Transporter.

Expression of ectonucleotidase CD39 by Foxp3 + Treg cells: hydrolysis of extracellular ATP and immune suppression

Dasatinib (BMS354825) Inhibits IgE-Dependent Activation and Histamine Release in Human Blood Basophils.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only